U.S. Infrastructure Stock News

Earlier this month, The Wendy's Company announced the resignation of Chief Accounting Officer Suzanne M. Thuerk and the appointment of long-time executive Aaron M. Kale, while also rolling out a Minions & Monsters-themed limited-time menu, collectibles, and an immersive drive-thru experience in Los Angeles tied to Illumination's new film. This combination of leadership continuity in the finance function and a high-profile entertainment partnership highlights Wendy's dual focus on operational...

Why Park National stock is on investors’ radar Park National (PRK) has drawn attention after a solid run in its stock price over the past month and past 3 months, prompting investors to reassess what they are paying for its underlying banking business. See our latest analysis for Park National. Recent share price momentum has been steady, with a 7.44% 30 day share price return and 12.60% over 90 days, while the 1 year total shareholder return of 15.27% sits alongside an 81.15% 3 year total...

The sudden move toward ending the Iran war and reopening the Strait of Hormuz has jolted the global energy sector, with oil prices slipping but still sitting well above pre war levels. For investors, this mix of easing tensions and ongoing supply uncertainty creates both potential openings and fresh risks. This article highlights 3 large energy stocks from our Global Energy Sector screener that are most exposed to these developments in a potentially positive way. Across these companies, you...

In early June 2026, KeyCorp filed multi-class shelf registrations, including up to US$3.36 billion of common shares, and later issued senior and subordinated notes due 2031, adding fresh flexibility to raise both equity and debt capital. This mix of potential equity issuance, broad financing tools, and a concurrent fixed-income offering highlights management’s emphasis on balance sheet optionality and funding diversification. We’ll now examine how this expanded funding capacity, especially...

Lantheus Holdings (LNTH) recently drew attention after its investigational PET/CT agent LNTH-2513 (18F-GP1) received SNMMI’s Image of the Year award, backed by trial data on diagnosing acute lower-extremity deep vein thrombosis. See our latest analysis for Lantheus Holdings. The recent SNMMI recognition and upcoming Goldman Sachs healthcare conference appearance come as the stock trades at US$104.67, with a 30-day share price return of 11.46% and a year to date share price return of 55.60%,...

DigitalOcean Holdings (DOCN) is back in focus after the company appointed three senior executives with deep roots in cloud and AI infrastructure, shortly after rolling out its AI-Native Cloud platform. See our latest analysis for DigitalOcean Holdings. The share price has moved sharply in recent months, with a 30-day share price return of 17.06% and a 90-day share price return of 133.65%. The 1-year total shareholder return is also very large, suggesting momentum has strengthened around the...

Medpace Holdings overview after recent share performance Medpace Holdings (MEDP) has drawn fresh attention after a solid move in its share price over the past month, inviting investors to review how its current valuation lines up with recent fundamentals. See our latest analysis for Medpace Holdings. That recent 12.6% 1 month share price return stands out against a weaker year to date share price return, while a 1 year total shareholder return of 56.9% suggests longer term holders have still...

Qualys (QLYS) has drawn investor attention after recent price moves, with the stock up about 27% over the past month and about 21% over the past 3 months from its recent levels. See our latest analysis for Qualys. Despite the recent momentum, with a 30 day share price return of 27.36% and a 90 day share price return of 20.58%, Qualys still has a year to date share price return decline of 12.49% and a 1 year total shareholder return decline of 17.66%. Recent gains are rebuilding after a weaker...

In recent trading, Everus Construction Group was caught in a past broad selloff across the engineering and construction sector, with investors rotating away from the space as peers also weakened. The steeper reaction in Everus shares compared with sector peers hints at investor sensitivity to sector-wide swings, even without fresh company-specific developments. We’ll now examine how this sector-wide pressure on engineering and construction stocks could influence Everus Construction Group’s...

Eli Lilly (NYSE:LLY) reported that its non-covalent BTK inhibitor Jaypirca reduced the risk of disease progression or death by 45% in the Phase 3 BRUIN CLL-322 trial for relapsed or refractory CLL/SLL. The trial evaluated Jaypirca in combination with standard therapy in patients who had already received BTK inhibitors. Lilly also shared early Phase 1 data for AJX-101, a first-in-class type II JAK2 inhibitor in myelofibrosis patients resistant to current treatments. These updates underscore...

Abercrombie & Fitch (ANF) is in focus after opening a new SoHo flagship alongside aggressive summer promotions, including sitewide discounts and targeted offers, moves that spotlight how management is thinking about customer growth and brand reach. See our latest analysis for Abercrombie & Fitch. Investors have watched momentum pick up again recently, with a 14.56% 7 day share price return and 29.09% 30 day share price return, even as the year to date share price return is down 26.38%. At the...

Tenet Healthcare recently attracted attention after analysts raised earnings estimates for the year, highlighting a projected 4.9% increase in EPS and stronger expected cash flow growth than the broader industry. This combination of upward estimate revisions, a favorable Zacks Rank #2, and an A Growth Score reinforces the market’s focus on Tenet’s potential as a growth-oriented healthcare operator. Next, we’ll examine how these upgraded earnings expectations and stronger cash flow prospects...

Chubb (CB) has been drawing attention after recent share price moves, with the stock last closing at US$326.95. For investors, the key question is how this valuation lines up with Chubb’s fundamentals. See our latest analysis for Chubb. While the recent 1-day share price return declined 0.36%, the stock has still recorded a 5.45% share price return year to date and a 15.60% total shareholder return over the past year, suggesting momentum has been broadly positive despite short term...

Recent share performance and business scale JPMorgan Chase (JPM) has attracted attention after recent trading, with the stock last closing at US$319.40. For context, the bank carries a market value of about US$859.4b. Over the past week the share price gained about 2.7%, with a move of roughly 7.2% over the past month and about 11.3% over the past 3 months. Over the past year, the total return is about 20.4%. The group operates across Consumer & Community Banking, Commercial & Investment...

When the Federal Reserve is weighing a more hawkish stance and inflation sits above 4%, stable dividend growth can look appealing, but not all dividend stocks react the same way to rate and inflation headlines. The latest Fed meeting and US Iran peace developments around the Strait of Hormuz may shift expectations for energy prices, inflation, and future policy guidance, which can help or hurt different dividend payers. This article walks through three dividend growth stocks from our screener...

Recent performance snapshot and what it means for IDEX (IEX) IDEX (IEX) has drawn fresh attention after a steady run, with the stock last closing at US$222.04 and total return figures highlighting how the company has been tracking over different holding periods. Over the past month, IDEX shows a 6.9% return, and about 16.6% over the past 3 months, with year to date performance at 24% and a 1 year total return of 25.3%. Longer holding periods show total returns of 10.3% over 3 years and 9%...

Penny stocks can look exciting when markets are reacting to shifting energy prices, central bank signals and mixed growth data, but the real opportunity often sits with the smaller companies that still keep their balance sheets in good shape. The Financially Fit Penny Stocks screener focuses on stocks trading below 5 that combine early stage potential with relatively stronger financial health, aiming to filter out some of the riskiest options. In this article, you will see three stocks from...

If you are wondering whether Moelis stock at around US$69.09 still offers value, or if most of the upside is already reflected in the price, this article breaks down what the current price might be implying about the company. The stock has returned 0.6% over the past week and 8.4% over the past month, while year to date it is down 3.0% but shows a 26.8% return over 1 year, 73.1% over 3 years and 67.5% over 5 years. Recent news coverage of Moelis has focused on the broader interest in capital...

Lululemon athletica (LULU) drew fresh attention after first quarter 2026 results showed revenue of US$2.47b, alongside a lower net income figure and reduced earnings outlook, set against firm international growth and North American pressure. See our latest analysis for lululemon athletica. Lululemon’s share price has fallen 27.04% over the past 90 days and is down 44.87% year to date, while the 1 year total shareholder return has declined 51.84%. This points to fading momentum as earnings...

Target (NYSE:TGT) has appointed designer Isaac Mizrahi as its first creative director at large. Mizrahi will mentor Target's in house design team, guide product development, and support new brand partnerships. The role also includes launching a mentorship program aimed at developing emerging creative talent within the company. For investors watching NYSE:TGT, this move comes with the stock trading at $133.17, after returns of 7.4% over the past week and 9.6% over the past month. The shares...

Earlier this month, One New Zealand Limited announced it had overhauled its complex enterprise mobile provisioning workflow using UiPath Maestro, deploying AI agents and software robots across Salesforce, Oracle, and internal systems to move from multi-day order cycles to near real-time provisioning with greater visibility and control. This rapid five-week rollout, and One New Zealand’s plan to extend Maestro into finance, risk, fraud, IT, and wider operations, underscores how UiPath is...

Investors may be wondering if CECO Environmental at around US$95 per share still offers value, or if most of the opportunity is already priced in. The stock recently closed at US$95.01, with returns of 18.0% over 7 days, 17.5% over 30 days, 58.9% year to date and 224.3% over the past year, while the 3‑year and 5‑year returns are very large. Recent attention on CECO Environmental has centred on its share price strength and how the market is reassessing the company within the broader machinery...

EGFR Market Attention Puts Focus on ArriVent BioPharma Recent commentary on the EGFR inhibitor market, highlighting precision medicine trends and ArriVent BioPharma (AVBP) firmonertinib trials in non small cell lung cancer, has pushed this clinical stage stock back onto investor watchlists. See our latest analysis for ArriVent BioPharma. At a latest share price of US$30.30, ArriVent's short term share price return has been relatively steady. The 30 day share price return of 8.7% and year to...

Everest Group Ltd. recently appointed Peter Chalkias as Australia country head and chief financial officer, bringing expertise in financial risk, risk management, accounting, financial planning, and business process improvement to its expanding international operations. This leadership move underlines Everest Group’s intent to sharpen financial discipline and operational oversight in a key growth market for its reinsurance and insurance franchise. Next, we’ll explore how Chalkias’s...